Epidemiology of Dystonia in a Multi-Ethnic Population

多民族人群肌张力障碍的流行病学

基本信息

  • 批准号:
    7469952
  • 负责人:
  • 金额:
    $ 88.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-23 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Dystonia is a disabling neurodegenerative disease that causes sustained involuntary muscle contractions, producing twisting, repetitive and patterned movements or abnormal postures. While it is the third most common movement disorder, little is known about ethnic or racial variation in the occurrence of dystonia or about risk factors. To address this problem, we will establish a dystonia incident cohort identified from among approximately 3 million individuals in a large, multiethnic (~40% non-white) health maintenance organization. We expect to identify at least 1000 incident cases of primary torsion dystonia (PTD). This will constitute by far the largest population of PTD patients ever enrolled in an epidemiologic study and will provide the foundation for addressing, for the first time, a number of questions regarding the epidemiology of dystonia. The first aim of this application is to estimate the incidence and prevalence of PTD overall and for clinically-defined subtypes (including generalized, cranial, cervical, limb and laryngeal dystonias). Incidence and prevalence within groups will be estimated by age, gender and race/ethnicity. This will be the first epidemiologic study of PTD of all types in a racially and ethnically diverse population. The second aim will be to investigate familial aggregation of dystonia in cases and controls, as measured by validated family history interviews, and to determine if this varies by subtype of dystonia and ethnicity. The third aim is to determine the frequency of the DYT1 mutation, associated with PTD, within groups defined by ethnicity and clinical features. Aim 4 is to investigate the role of environmental exposures that may influence the expression of dystonia and the penetrance of the known gene (DYT1), including specific antecedent health events (trauma, infection) or lifestyle factors (occupation, hobbies, cigarette smoking, physical activity) by comparing the frequency of these events before dystonia onset in cases and approximately 1000 matched controls. This will be the first investigation of the incidence, prevalence, and associated risk factors of PTD in-a large unselected multiethnic population. It will be the largest population of PTD ever studied epidemiologically. Advantages of the study setting include: (1) it is demographically similar to the underlying population of northern California, (2) access to care is unrestricted, reducing biased ascertainment, (3) a large control population is available and (4) certain health-related risk factors can be identified through computerized records, minimizing recall bias. These investigations have the potential to provide significant insights into the determinants of dystonia. In addition, this cohort will provide a rich resource for future investigations including family studies, genetic analyses and further investigations of environmental risk factors.
描述(由申请人提供):肌张力障碍是一种致残性神经退行性疾病,可导致持续的不自主肌肉收缩,产生扭曲、重复和模式化运动或异常姿势。虽然它是第三种最常见的运动障碍,但对肌张力障碍发生的种族或种族差异或危险因素知之甚少。为了解决这个问题,我们将建立一个肌张力障碍事件队列,从一个大型的多种族(~40%非白人)健康维护组织的约300万人中确定。我们预计将发现至少1000例原发性扭转性肌张力障碍(PTD)病例。这将构成迄今为止流行病学研究中招募的最大PTD患者人群,并将首次为解决有关肌张力障碍流行病学的许多问题提供基础。本申请的第一个目的是估计PTD总体和临床定义亚型(包括全身性、颅、颈、肢体和喉肌张力障碍)的发病率和患病率。将按年龄、性别和人种/种族估计组内的发病率和患病率。这将是第一个在不同种族和民族人群中进行的所有类型PTD的流行病学研究。第二个目的是调查病例和对照组中肌张力障碍的家族聚集性,通过有效的家族史访谈进行测量,并确定这是否因肌张力障碍亚型和种族而异。第三个目的是确定与PTD相关的DYT 1突变的频率,在由种族和临床特征定义的组中。目的4是研究环境暴露的作用,可能会影响肌张力障碍的表达和已知基因(DYT 1)的表达,包括特定的先行健康事件(创伤,感染)或生活方式因素(职业,爱好,吸烟,体育活动)通过比较这些事件的频率肌张力障碍发病前的情况下,大约1000匹配的对照。这将是第一次调查的发病率,患病率,和相关的危险因素,PTD在一个大的跨种族人口。这将是有史以来流行病学研究的最大的PTD人群。研究设置的优势包括:(1)在人口统计学上与北方加州的基础人群相似,(2)获得护理不受限制,减少了偏倚确定,(3)可获得大量对照人群,(4)可通过计算机记录识别某些健康相关风险因素,最大限度地减少回忆偏倚。这些研究有可能为肌张力障碍的决定因素提供重要的见解。此外,该队列将为未来的调查提供丰富的资源,包括家庭研究,遗传分析和环境风险因素的进一步调查。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Caroline M. Tanner其他文献

Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts
PPMI、PASADENA 和 SPARK 基线队列中神经元α-突触核蛋白病综合分期系统的性能
  • DOI:
    10.1038/s41531-024-00789-w
  • 发表时间:
    2024-09-27
  • 期刊:
  • 影响因子:
    8.200
  • 作者:
    Tien Dam;Gennaro Pagano;Michael C. Brumm;Caroline Gochanour;Kathleen L. Poston;Daniel Weintraub;Lana M. Chahine;Christopher Coffey;Caroline M. Tanner;Catherine M. Kopil;Yuge Xiao;Sohini Chowdhury;Luis Concha-Marambio;Peter DiBiaso;Tatiana Foroud;Mark Frasier;Danna Jennings;Karl Kieburtz;Kalpana Merchant;Brit Mollenhauer;Thomas J. Montine;Kelly Nudelman;John Seibyl;Todd Sherer;Andrew Singleton;Diane Stephenson;Matthew Stern;Claudio Soto;Eduardo Tolosa;Andrew Siderowf;Billy Dunn;Tanya Simuni;Kenneth Marek
  • 通讯作者:
    Kenneth Marek
Randomized, trial extended-release for
随机、试验延长释放
  • DOI:
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wolfgang H. Oertel;Karla Eggert;R. Pahwa;Caroline M. Tanner;Robert A. Hauser;C. Trenkwalder;R. Ehret;J. Azulay;S. Isaacson;Larissa Felt;M. Stempien
  • 通讯作者:
    M. Stempien
Benefits and Risks of Pharmacological Treatments for Essential Tremor
  • DOI:
    10.2165/00002018-200326070-00003
  • 发表时间:
    2003-01-01
  • 期刊:
  • 影响因子:
    3.800
  • 作者:
    Kelly E. Lyons;Rajesh Pahwa;Cynthia L. Comella;Mahmood S. Eisa;Rodger J. Elble;Stanley Fahn;Joseph Jankovic;Jorge L. Juncos;William C. Koller;William G. Ondo;Kapil D. Sethi;Matthew B. Stern;Caroline M. Tanner;Ron Tintner;Ray L. Watts
  • 通讯作者:
    Ray L. Watts
Survival in Parkinson disease
帕金森病患者的生存率
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    9.9
  • 作者:
    Connie Marras;Michael P. McDermott;Paula A. Rochon;Caroline M. Tanner;Gary Naglie;Alice Rudolph;Anthony E. Lang
  • 通讯作者:
    Anthony E. Lang
Abnormal liver enzyme‐mediated metabolism in Parkinson's disease
帕金森病中肝酶介导的代谢异常
  • DOI:
    10.1212/wnl.41.5_suppl_2.89
  • 发表时间:
    1991
  • 期刊:
  • 影响因子:
    9.9
  • 作者:
    Caroline M. Tanner
  • 通讯作者:
    Caroline M. Tanner

Caroline M. Tanner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Caroline M. Tanner', 18)}}的其他基金

Diagnostic Error in Dystonia
肌张力障碍的诊断错误
  • 批准号:
    7933752
  • 财政年份:
    2009
  • 资助金额:
    $ 88.43万
  • 项目类别:
Diagnostic Error in Dystonia
肌张力障碍的诊断错误
  • 批准号:
    7785414
  • 财政年份:
    2009
  • 资助金额:
    $ 88.43万
  • 项目类别:
Epidemiology of Dystonia in a Multi-Ethnic Population
多民族人群肌张力障碍的流行病学
  • 批准号:
    7644835
  • 财政年份:
    2005
  • 资助金额:
    $ 88.43万
  • 项目类别:
Epidemiology of Dystonia in a Multi-Ethnic Population
多民族人群肌张力障碍的流行病学
  • 批准号:
    7272676
  • 财政年份:
    2005
  • 资助金额:
    $ 88.43万
  • 项目类别:
Epidemiology of Dystonia in a Multi-Ethnic Population
多民族人群肌张力障碍的流行病学
  • 批准号:
    7125100
  • 财政年份:
    2005
  • 资助金额:
    $ 88.43万
  • 项目类别:
Epidemiology of Dystonia in a Multi-Ethnic Population
多民族人群肌张力障碍的流行病学
  • 批准号:
    6976884
  • 财政年份:
    2005
  • 资助金额:
    $ 88.43万
  • 项目类别:
RISK FACTORS FOR MSA
MSA 的风险因素
  • 批准号:
    6825108
  • 财政年份:
    2003
  • 资助金额:
    $ 88.43万
  • 项目类别:
Large Simple Neuroprotective Trials in Parkinson's Disease
帕金森病的大型简单神经保护试验
  • 批准号:
    7157549
  • 财政年份:
    2002
  • 资助金额:
    $ 88.43万
  • 项目类别:
Skin Pigmentation and Parkinson's Disease Risk
皮肤色素沉着和帕金森病风险
  • 批准号:
    6480198
  • 财政年份:
    2002
  • 资助金额:
    $ 88.43万
  • 项目类别:
Continuation of NET-PD Trials at The Parkinson's Institute
帕金森研究所继续进行 NET-PD 试验
  • 批准号:
    8458275
  • 财政年份:
    2002
  • 资助金额:
    $ 88.43万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 88.43万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 88.43万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 88.43万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 88.43万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 88.43万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 88.43万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 88.43万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 88.43万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 88.43万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 88.43万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了